Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
19 hedge funds and large institutions have $5.01M invested in Intellipharmaceuticals International Inc. in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.
2% more capital invested
Capital invested by funds: $4.9M → $5.01M (+$110K)
10% less funds holding
Funds holding: 21 → 19 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
98% less call options, than puts
Call options by funds: $12K | Put options by funds: $509K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$49K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$5.34K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.71K |
| 4 |
PCM
Prelude Capital Management
New York
|
+$2.67K |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$1.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$631K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$89K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$80.3K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$54K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$29.1K |
IPCI Hedge Fund Activity: Q1 2015 in Review
19 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q1 2015, worth a combined $5.01M — up 2.2% from $4.9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IPCI and 4 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 3 added.
The largest buyer was Rotella Capital Management, opening a new position worth an estimated $49K. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $631K sold.
- 19 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q1 2015, down from 21 in Q4 2014.
- Funds reported $5.01M of Intellipharmaceuticals International Inc. stock for Q1 2015, up 2.2% quarter-over-quarter.
- 4 funds opened new Intellipharmaceuticals International Inc. positions in Q1 2015 and 6 closed out, a net change of -2 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q1 2015 was Rotella Capital Management, an estimated $49K added.
- The largest Intellipharmaceuticals International Inc. seller in Q1 2015 was DAFNA Capital Management, an estimated $631K sold.
Based on aggregated 13F filings for Q1 2015.